Document is current
Any future updates will be listed below
-
Authors
Kassir, Sarah https://orcid.org/0009-0007-8268-4600
Duloquin, Gauthier https://orcid.org/0000-0002-5351-7869
Béjot, Yannick https://orcid.org/0000-0001-7848-7072
-
Funding
Funding for this research was provided by:
Santé Publique France
Inserm
CHU Dijon Bourgogne
Fondation Clément Drevon
Université Bourgogne Europe
- License Information
-
More Information
Article History
Received: 11 February 2026
Revised: 14 March 2026
Accepted: 17 March 2026
First Online: 1 April 2026
Declarations
:
: Yannick Béjot reports personal fees from AstraZeneca, BMS, Pfizer, Medtronic, MSD France, Amgen, Servier, and Boehringer-Ingelheim, outside the submitted work. Sarah Kassir and Gauthier Duloquin: none.
: The Dijon Stroke Registry was approved by the Comité d’Evaluation des Registres (French National Committee of Registers), Santé Publique France (French Institute for Public Health Surveillance), the Commission Nationale Informatique et Liberté (French data protection authority), and Comité de Protection des Personnes (Ethics Committee). In accordance with the French legislation, boards waived the need for written patient consent, but all patients or their relatives received written information and did not oppose the use of their data for this study.
: Not applicable.
